|
|
|
| Study of compounds might yield way to block cancer, other diseases |
| |
 |
|
| |
Dr. Lawrence Lum
|
|
| |
|
|
Screening a chemical library of 200,000 compounds, researchers at
UT Southwestern have identified two new classes that can be used to study and possibly manipulate a cellular pathway involved in many types of cancer and degenerative diseases. “The identification of these chemicals and their targets within this cellular pathway represents an important step in developing therapeutic agents,” said Dr. Lawrence Lum, assistant professor of cell biology and senior author of the study, available at Nature Chemical Biology.
Read More
Study: Vaginal/Caesarian delivery of twins is safe
Doctors need not go straight to Caesarean section when delivering twins, but can start with vaginal delivery of the first twin in many cases, researchers have found in a study led by UT Southwestern. Read More
Interferon fails to slow liver disease
Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, UT Southwestern researchers and their colleagues from nine other institutions have found in a multicenter study. Read More
Type 1 diabetes patients sought for investigational drug trial
UT Southwestern researchers are recruiting individuals newly diagnosed with type 1 diabetes for a clinical trial to gauge the effectiveness of adding an investigational stem cell product to standard insulin therapy. Read More |
|
|
